Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Nemus Bioscience, Inc. (NMUS) Starts Presentation at 2015 Marcum MicroCap Conference

Nemus Bioscience is a biopharmaceutical company with a focus on the discovery, development and commercialization of therapeutics based on naturally derived or synthetically manufactured cannabis compounds. The company develops therapeutic products to treat glaucoma and other optic nerve-related disorders and conditions associated with muscle spasticity, epilepsy, anxiety and methicillin-resistant staphylococcus aureus. Founded in 2012, Nemus Bioscience is based in Costa Mesa, California. For more information, visit the company’s website at

The Marcum MicroCap Conference is a forum where publicly traded companies with less than $500 million in market capitalization can network with the investment community. The two-day 2016 conference will include feature presentations by CEOs and CFOs from seven principal industry sectors, expert panels moderated by industry leaders, and the opportunity to meet with management of presenting companies on a one-on-one basis. Marcum is partnered with KCSA Strategic Communications to present this year's Marcum MicroCap Conference.
This entry was posted in Marcum MicroCap. Bookmark the permalink.

Comments are closed.